IsopongachromeneCAS# N/A |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | N/A | SDF | Download SDF |
| PubChem ID | 44257584 | Appearance | Powder |
| Formula | C22H18O6 | M.Wt | 378.4 |
| Type of Compound | Chalcones/Dihydrochalcones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 2-(1,3-benzodioxol-5-yl)-6-methoxy-8,8-dimethylpyrano[2,3-h]chromen-4-one | ||
| SMILES | CC1(C=CC2=C3C(=CC(=C2O1)OC)C(=O)C=C(O3)C4=CC5=C(C=C4)OCO5)C | ||
| Standard InChIKey | CKTFYXPCWPPHAT-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C22H18O6/c1-22(2)7-6-13-20-14(9-19(24-3)21(13)28-22)15(23)10-17(27-20)12-4-5-16-18(8-12)26-11-25-16/h4-10H,11H2,1-3H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Isopongachromene Dilution Calculator
Isopongachromene Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.6427 mL | 13.2135 mL | 26.4271 mL | 52.8541 mL | 66.0677 mL |
| 5 mM | 0.5285 mL | 2.6427 mL | 5.2854 mL | 10.5708 mL | 13.2135 mL |
| 10 mM | 0.2643 mL | 1.3214 mL | 2.6427 mL | 5.2854 mL | 6.6068 mL |
| 50 mM | 0.0529 mL | 0.2643 mL | 0.5285 mL | 1.0571 mL | 1.3214 mL |
| 100 mM | 0.0264 mL | 0.1321 mL | 0.2643 mL | 0.5285 mL | 0.6607 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Cichoric acid
Catalog No.:BCN9033
CAS No.:6537-80-0
- Anethole, trans-
Catalog No.:BCN9032
CAS No.:4180-23-8
- Galactaric acid
Catalog No.:BCN9031
CAS No.:526-99-8
- (±)-Nicotine
Catalog No.:BCN9030
CAS No.:22083-74-5
- Cynatratoside C
Catalog No.:BCN9029
CAS No.:
- Byakangelicin
Catalog No.:BCN9028
CAS No.:482-25-7
- Neolancerin
Catalog No.:BCN9027
CAS No.:117221-65-5
- (-)-Carvone
Catalog No.:BCN8949
CAS No.:6485-40-1
- Cyanidin-3-O-(6''-malonylglucoside) chloride
Catalog No.:BCN9026
CAS No.:171828-62-9
- Sipeimine-3-beta-D-glucoside
Catalog No.:BCN9025
CAS No.:67968-40-5
- Robinetinidin chloride
Catalog No.:BCN9024
CAS No.:3020-09-5
- (+)-Mediresinol Di-O-beta-D-glucopyranoside
Catalog No.:BCN9023
CAS No.:88142-63-6
- 1-Naphthaleneacetic acid
Catalog No.:BCN9035
CAS No.:86-87-3
- Kizuta saponin K11
Catalog No.:BCN9036
CAS No.:97240-03-4
- D-(+)-Lactose Monohydrate
Catalog No.:BCN9037
CAS No.:64044-51-5
- Ganoderic acid E
Catalog No.:BCN9038
CAS No.:
- Fluoranthene
Catalog No.:BCN9039
CAS No.:206-44-0
- DL-α-Tocopherol
Catalog No.:BCN9040
CAS No.:10191-41-0
- Peimisine hydrochloride
Catalog No.:BCN9041
CAS No.:900498-44-4
- (+)-Secoisolariciresinol
Catalog No.:BCN9042
CAS No.:145265-02-7
- Allocryptopine
Catalog No.:BCN9043
CAS No.:485-91-6
- Quininic acid
Catalog No.:BCN9044
CAS No.:86-68-0
- Menthol
Catalog No.:BCN9045
CAS No.:89-78-1
- Atractyloside potassium salt
Catalog No.:BCN9046
CAS No.:17754-44-8
Inhibitory effects on Streptococcus mutans of antibacterial agents mixed with experimental fluoride varnish.[Pubmed:32522914]
Dent Mater J. 2020 Jun 9.
We investigated the inhibitory effect of antibacterial agents mixed with experimental fluoride varnish (EFV) on Streptococcus mutans. The antibacterial agents used were (1 and 10) mM of xanthorrhizol, bakuchiol, bavachalcone, isobavachromene, and bavachromene. Agar diffusion tests were performed on S. mutans (1.1x10(10) CFU/mL), using antibacterial agents without and with EFV. Bavachalcone showed the highest inhibition zone without and with EFV at both (1 and 10) mM (p<0.05). All EFV with antibacterial agents showed greater inhibition and semi-inhibition zones than EFV alone (p<0.05). The cell viability of each antibacterial agent was not significantly different from the vehicle controls (p>0.05), except xanthorrhizol and bakuchiol at 1 mM. All antibacterial agents were effective, while antibacterial agents with EFV co-formulations were more effective than EFV alone. Bavachalcone was the most effective agent against S. mutans, indicating its potential usefulness with fluoride varnish in preventing dental caries.
Estrogenic activities of Psoralea corylifolia L. seed extracts and main constituents.[Pubmed:21382704]
Phytomedicine. 2011 Mar 15;18(5):425-30.
Estrogenic activities of ethanol extract and its active components from Psoralea corylifolia L. were studied using various in vitro assays. The main components from ethanol extract were analyzed to be bakuchiol, psoralen, isobavachalcone, isobavachromene, and bavachinin. In a fractionation procedure, hexane and chloroform fractions showed estrogenic activity in yeast transactivation assay and E-screen assay. In yeast transactivation assay, ethanol extract, hexane, and chloroform fractions showed significantly higher activities at a concentration of 1.0 ng/ml, and bakuchiol at the concentration of 10(-6) M was showed the highest activity, especially, which was higher than genistein at the same concentration. In E-screen assay, cell proliferation of bakuchiol (10(-6) M) showed similar estrogenic activity with genistein (10(-6) M). In ER binding assay, bakuchiol displayed the strongest ER-binding affinity (IC(50) for ERalpha=1.01x10(-6) M, IC(50) for ERbeta=1.20x10(-6) M) and bakuchiol showed five times higher affinity for ERalpha than for ERbeta.
In vitro BACE-1 inhibitory phenolic components from the seeds of Psoralea corylifolia.[Pubmed:18666047]
Planta Med. 2008 Sep;74(11):1405-8.
A new isoflavone, neocorylin ( 1) was isolated from the seeds extract of Psoralea corylifolia L. (Fabaceae), together with eight known constituents ( 2 - 9), i. e., bakuchiol ( 2), psoralen ( 3), bavachromene ( 4), isobavachromene ( 5), bavachalcone ( 6), isobavachalcone ( 7), 7,8-dihydro-8-(4-hydrophenyl)-2,2-dimethyl-2 H,6 H-[1,2- B:5,4- B']dipyran-6-one ( 8), and bavachinin ( 9). The structure of the new isoflavone 1 was elucidated as 7-hydroxy-3-[2-methyl-2-(4-methylpenten-3-yl)-2 H-chromen-6-yl]-4 H-chromen-4-one by spectroscopic analyses. Neocorylin ( 1) as well as related compounds 2, 4 - 6, 8 and 9 exhibited a significant inhibitory effect on baculovirus-expressed BACE-1 in vitro.
